Ra Pharmaceuticals Inc (RARX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RARX | RNA | VCEL | ||
| Company | Ra Pharmaceuticals Inc | Avidity Biosciences Inc | Vericel Corporation | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 47.99 | 24.15 | 46.04 | ||
| High | 48.01 | 26.97 | 48.65 | ||
| Low | 47.98 | 23.92 | 45.46 | ||
| Last | 48.00 | 25.80 | 47.08 | ||
| Change | -0.02 | +1.67 | +1.21 | ||
| % Change | -0.03% | +6.92% | +2.64% | ||
| Volume | 3,864,600 | 1,167,100 | 471,900 | ||
| 20-Day Average Volume | 1,869,975 | 955,130 | 318,765 | ||
| Previous Close | 48.01 | 24.13 | 45.87 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 46.03 | 24.42 | 47.35 | ||
| 20-Day Raw Stochastic | 99.68% | 75.58% | 49.71% | ||
| 20-Day Relative Strength | 56.47% | 60.45% | 50.86% | ||
| Weighted Alpha | +21.70 | +129.85 | +46.30 | ||
| Today's Opinion | 56% Buy | 100% Buy | 56% Buy | ||
| Previous Opinion | 56% Buy | 80% Buy | 56% Buy | ||
| Last Month's Opinion | 80% Buy | 100% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.91% since 03/25/20 | +2.83% since 04/24/24 | +2.10% since 04/24/24 | ||
| Low | 46.34 on 03/26/20 | 23.35 on 04/25/24 | 44.50 on 04/25/24 | ||
| High | 48.02 on 03/31/20 | 26.97 on 05/01/24 | 48.65 on 05/01/24 | ||
| 1-Month | |||||
| %Chg | +2.64% since 02/28/20 | -2.27% since 04/01/24 | -11.00% since 04/01/24 | ||
| Low | 40.30 on 03/18/20 | 21.56 on 04/04/24 | 42.38 on 04/19/24 | ||
| High | 48.02 on 03/31/20 | 27.66 on 04/03/24 | 52.50 on 04/02/24 | ||
| 3-Month | |||||
| %Chg | +2.27% since 12/31/19 | +112.52% since 02/01/24 | +7.86% since 02/01/24 | ||
| Low | 40.30 on 03/18/20 | 11.23 on 02/05/24 | 41.58 on 02/07/24 | ||
| High | 48.02 on 03/31/20 | 27.66 on 04/03/24 | 53.05 on 04/01/24 | ||
| 6-Month | |||||
| %Chg | +112.27% since 10/01/19 | +403.91% since 11/01/23 | +34.51% since 11/01/23 | ||
| Low | 22.25 on 10/08/19 | 5.04 on 11/02/23 | 32.28 on 11/09/23 | ||
| High | 48.02 on 03/31/20 | 27.66 on 04/03/24 | 53.05 on 04/01/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 2,271,555 | 2,307,431 | 2,219,191 | ||
| Shares Outstanding, K | 47,329 | 95,625 | 48,380 | ||
| Annual Sales | 3,000,000 | 9,560,000 | 197,520,000 | ||
| Annual Net Income | -102,690,000 | -212,220,000 | -3,180,000 | ||
| Last Quarter Sales | 3,000,000 | 2,190,000 | 65,000,000 | ||
| Last Quarter Net Income | -24,980,000 | -60,440,000 | 12,990,000 | ||
| 60-Month Beta | 1.04 | 0.78 | 1.71 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -0.79 on 02/28/24 | 0.26 on 02/29/24 | ||
| Latest Earnings Date | 05/14/20 | 05/14/24 | 05/08/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||